ABOUT WERFEN
Powering Patient Care
In everything we do, we use our passion and long-term vision to develop meaningful innovations that truly enhance patient care and help create healthier societies worldwide.
Werfen at a glance
Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain.
We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant. Through our Original Equipment Manufacturing (OEM) business line, we research, develop, and manufacture customized assays and biomaterials.
We operate directly in 30 countries, and in more than 100 territories through distributors. Our Headquarters and Technology Centers are located in the US and Europe. Worldwide sales exceed €1.84 billion in 2022, and our workforce is more than 7,000 strong.
Clinical areas of expertise
We are a worldwide leader in specialized diagnostics in the specialties of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity and Transplant. Through our OEM business line, we research, develop and manufacture customized assays and biomaterials.
Our Hemostasis product portfolio comprises in vitro diagnostic systems, reagents, data management solutions, automation, and service, used to diagnose and guide treatment of thrombotic and bleeding disorders. Ultimately, Werfen's Hemostasis solutions improve the quality of patient care, lower costs, and assure regulatory compliance in the clinical laboratory.
From cardiovascular operating rooms and catheterization labs, to intensive care units and emergency departments, Werfen’s Acute Care Diagnostic solutions are integrated and comprehensive. This whole blood testing portfolio line helps clinicians and laboratorians save time, lower costs, assure regulatory compliance and improve patient outcomes.
Through a dedicated focus on in vitro diagnostics and lab automation for Autoimmunity, our highly accurate reagents and automated systems are designed to serve labs of all sizes. Werfen’s solutions help improve the way patients with Autoimmune diseases are diagnosed, monitored, and treated.
Our consolidated experience spans research, development and manufacturing of customized assays and biomaterials. We have significantly contributed to hemostasis and autoimmunity diagnostics, while offering end-to-end solutions for the IVD industry with the most innovative capabilities, enhancing unique product features, and reducing time-to-market.
Our Code of Ethics
The Werfen Code of Ethics demonstrates our commitment to integrity and the highest ethical standards. It guides our daily business behavior and shows the values we share throughout the organization.
Sustainability
We believe in the importance of sustainability for our people, our planet and our profitability.
We are a signatory of the UN Global Compact, and we commit to the UN Sustainable Development Goals:
- Proactively managing our internal operations and supply chain;
- Launching Corporate Social Responsibility programs;
- Diversity and Inclusion practices;
- Through the products, solutions, systems and services we offer our customers.
The 3P's of sustainability
We are focused on three areas - equally important and interconnected.
People
Social equality: Our commitment to human rights, security, equality, inclusion and diversity in all respects.
People
Planet
Environmental protection: Our impact on the environment including CO2 emissions, waste management or biodiversity.
Planet
Prosperity
Economic development: Our economic growth and our efficiency using resources like energy or materials.
Prosperity
WHAT'S HAPPENING
News
Something new is always happening in our world, keep up to date with news
June 10, 2022
June 2, 2022
May 25, 2022